Search Results - M. V. Soldatenko
- Showing 1 - 6 results of 6
-
1
-
2
Effect of β-blocker therapy on the level soluble ST2 protein in the blood serum in patients with heart failure with preserved and mildly reduced ejection fraction by E. V. Grakova, K. V. Kopeva, A. T. Teplyakov, M. V. Soldatenko, T. E. Suslova, V. V. Kalyuzhin
Published 2022-04-01
Article -
3
Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocar... by E. V. Grakova, A. T. Teplyakov, K. V. Kopieva, Sh. D. Akhmedov, O. N. Ogurkova, M. V. Soldatenko
Published 2018-10-01
Article -
4
-
5
-
6
Low-intensity inflammation as a manifestation of comorbidity and a factor in the unfavorable clinical course of heart failure with preserved ejection fraction by K. N. Vitt, E. A. Kuzheleva, O. V. Tukish, M. V. Soldatenko, M. Yu. Kondratiev, O. N. Ogurkova, T. E. Suslova, A. A. Garganeeva
Published 2024-03-01
Article